Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age: Maximum serum creatinine (mg/dL)\r\n** 2 to < 6 years: 0.8 (male) 0.8 (female)\r\n** 6 to < 10 years: 1 (male) 1 (female)\r\n** 10 to < 13 years: 1.2 (male) 1.2 (female)\r\n** 13 to < 16 years: 1.5 (male) 1.4 (female)\r\n** >= 16 years: 1.7 (male) 1.4 (female)Xx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/sex as follows:\r\n* 1 to < 2 years: male = 0.6; female = 0.6\r\n* 2 to < 6 years: male = 0.8; female = 0.8\r\n* 6 to < 10 years: male = 1; female = 1\r\n* 10 to < 13 years: male = 1.2; female = 1.2\r\n* 13 to < 16 years: male = 1.5; female = 1.4\r\n* >= 16 years: male = 1.7; female = 1.4Xx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age: maximum serum creatinine (mg/dL)\r\n* 1 to < 2 years: 0.6 (male and female) \r\n* 2 to < 6 years: 0.8 (male and female) \r\n* 6 to < 10 years: 1 (male and female) \r\n* 10 to < 13 years: 1.2 (male and female) \r\n* 13 to < 16 years: 1.5 (male), 1.4 (female) \r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age: maximum serum creatinine (mg/dL)\r\n* 1 to < 2 years: 0.6 (male and female) \r\n* 2 to < 6 years: 0.8 (male and female) \r\n* 6 to < 10 years: 1 (male and female) \r\n* 10 to < 13 years: 1.2 (male and female) \r\n* 13 to < 16 years: 1.5 (male), 1.4 (female) \r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXA serum creatinine based on age/gender as follows: (mg/dL)\r\n* 1 month to < 6 months male: 0.4 female: 0.4\r\n* 6 months to < 1 year male: 0.5 female: 0.5\r\n* 1 to < 2 years male: 0.6 female: 0.6\r\n* 2 to < 6 years male: 0.8 female: 0.8\r\n* 6 to < 10 years male: 1 female: 1\r\n* 10 to < 13 years male: 1.2 female: 1.2\r\n* 13 to < 16 years: male: 1.5 female: 1.4\r\n* >= 16 years male: 1.7 female: 1.4Xx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) > 70mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age: Maximum Serum Creatinine (mg/dL)\r\n* 1 to < 6 months: 0.4 (male) 0.4 (female)\r\n* 6 months to < 1 year: 0.5 (male) 0.5 (female)\r\n* 1 to < 2 years: 0.6 (male) 0.6 (female)\r\n* 2 < 6 years: 0.8 (male) 0.8 (female)\r\n* 6 to < 10 years: 1.0 (male) 1.0 (female)\r\n* 10 to < 13 years: 1.2 (male)\t1.2 (female)\r\n* 13 to < 16 years: 1.5 (male)\t1.4 (female)\r\n* > 16 years: 1.7 (male) 1.4 (female)Xx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or\r\n* A serum creatinine based on age/gender as follows:\r\n** Age: maximum serum creatinine (mg/dL)\r\n** 1 month to < 6 months: 0.4 (male and female)\r\n** 6 months to < 1 year: 0.5 (male and female)\r\n** 1 to < 2 years: 06 (male and female)\r\n** 2 to < 6 years: 0.8 (male and female)\r\n** 6 to < 10 years: 1 (male and female)\r\n** 10 to < 13 years: 1.2 (male and female)\r\n** 13 to < 16 years: 1.5 (male), 1.4 (female)\r\n** >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXMale or female subjects, age 18 years or olderXx_NEWLINE_xXMale or female, aged 18 years and olderXx_NEWLINE_xXSerum creatinine based on age/gender; patients that do not meet the criteria but have a 24 hour creatinine clearance or glomerular filtration rate (GFR) (radioisotope or iothalamate) >= 70 mL/min/1.73 m^2 are eligible\r\n* Age: Maximum serum creatinine (mg/dL)\r\n* 1 to < 2 years: 0.6 (male and female)\r\n* 2 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male) 1.4 (female)\r\n* >= 16 years: 1.7 (male) 1.4 (female)Xx_NEWLINE_xXMale or female, age 18 years or olderXx_NEWLINE_xXMale or female patients, age 18 years or older at the time of signing the informed consent form (ICF).Xx_NEWLINE_xXPatient (male or female) ?18 years of age willing to agree to not father a child/become pregnant and comply with effective contraception criteria.Xx_NEWLINE_xXFemale and male subjects ?18 years of age with one of the following:Xx_NEWLINE_xXMale or female ? 18 years of age.Xx_NEWLINE_xXMale or female patients 18 years of age or olderXx_NEWLINE_xXMale or female patients age 18 years and older, inclusive, at the time of informed consentXx_NEWLINE_xXMale or female patients aged ?18 yearsXx_NEWLINE_xXPatients must be a male or female ? 18 years of age on the day of signing informed consent.Xx_NEWLINE_xXSerum creatinine based on age/gender as follows:\r\n* Age 0 month to < 6 months; male 0.4; female 0.4\r\n* Age 6 months to < 1 year; male 0.5; female 0.5\r\n* Age 1 to < 2 years; male 0.6; female 0.6\r\n* Age 2 to < 6 years; male 0.8; female 0.8\r\n* Age 6 to < 10 years; male 1; female 1 \r\n* Age 10 to < 13 years; male: 1.2; female: 1.2\r\n* Age 13 to < 16 years; male: 1.5; female: 1.4\r\n* Age >= 16 years; male: 1.7; female: 1.4Xx_NEWLINE_xXAge 18 years or older, male or female.Xx_NEWLINE_xXMale and female subjects, age >=18 years (at the time consent is obtained).Xx_NEWLINE_xXIs male or female, aged 18 years or older at the time of consent; preferably non-Asian.Xx_NEWLINE_xXMale or female age 18 years or older.Xx_NEWLINE_xXFemale aged ? 18 years.Xx_NEWLINE_xXMale and female patients of any race, 18 years or olderXx_NEWLINE_xXMale and female who are 18 yrs or olderXx_NEWLINE_xXMale or female patient, age >18 yearsXx_NEWLINE_xXMale or female subjects who are at least 18 to 70 years of ageXx_NEWLINE_xXMale subjects must:Xx_NEWLINE_xXMale or Female at least 18 years of ageXx_NEWLINE_xXMale or female subjects at least 18 years of age.Xx_NEWLINE_xXMale or female patients aged ? 18 years.Xx_NEWLINE_xXMale or female ? 18 years of age at time of consent.Xx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age: Maximum serum creatinine (mg/dL)\r\n* 3 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male) 1.4 (female)\r\n* >= 16 years: 1.7 (male) 1.4 (female)Xx_NEWLINE_xXMale or female patients age ? 18 years of age at the time of informed consentXx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* 3 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male) 1.4 (female)\r\n* >= 16 years: 1.7 (male) 1.4 (female)Xx_NEWLINE_xXFemale or male ? 18 years of age.Xx_NEWLINE_xXFemale subject aged ? 18 years.Xx_NEWLINE_xXMale or female, ?18 years of age (?20 years of age in Taiwan)Xx_NEWLINE_xXMale or female aged 18 or olderXx_NEWLINE_xXCreatinine clearance (CrCl) or radioisotope glomerular filtration rate (GFR) ? 70 mL/min/1.73 m^2 OR a serum creatinine based on age/gender as follows:\r\n* 1 month to < 6 months (male) 0.4 (female) 0.4\r\n* 6 months to < 1 year  (male) 0.5 (female) 0.5\r\n* 1 to < 2 years (male) 0.6 (female) 0.6\r\n* 2 to < 6 years (male) 0.8 (female) 0.8\r\n* 6 to < 10 years (male) 1 (female) 1\r\n* 10 to < 13 years (male) 1.2 (female) 1.2\r\n* 13 to < 16 years (male) 1.5 (female) 1.4\r\n* ? 16 years (male) 1.7 (female) 1.4Xx_NEWLINE_xXMale or female ? 12 years of ageXx_NEWLINE_xXPatient (male or female) ?12 years of ageXx_NEWLINE_xXMale or female patients >/= 18 years of age with relapsed or refractory AMLXx_NEWLINE_xXMale or female aged ? 18 yearsXx_NEWLINE_xXMale or female ? 18 years of ageXx_NEWLINE_xXMale or female patient ? 18 years of ageXx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 ml/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* 1 to < 2 years: 0.6 (male), 0.6 (female)\r\n* 2 to < 6 years:\t0.8 (male), 0.8 (female)\r\n* 6 to < 10 years: 1 (male), 1 (female)\r\n* 10 to < 13 years: 1.2 (male), 1.2 (female)\r\n* 13 to < 16 years: 1.5 (male), 1.4 (female)\r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXMale or non-pregnant and non-lactating female, and ?18 years of age.Xx_NEWLINE_xXFemale or male patients ?18 years-of-ageXx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) 70 mL/min/1.73 m^2 or maximum serum creatinine (mg/dL) based on age/gender as follows:\r\n* 1-1.99 years, male 0.6, female 0.6\r\n* 2-5.99 years, male 0.8, female 0.8\r\n* 6-9.99 years, male 1, female 1\r\n* 10-12.99 years, male 1.2, female 1.2\r\n* 13-15.99 years, male 1.5, female 1.4\r\n* >= 16 years, male 1.7, female 1.4Xx_NEWLINE_xXA serum creatinine (mg/dL) based on age/gender as follows:\r\n* Age: 3 to < 6 years; Male: 0.8; Female: 0.8\r\n* Age: 6 to < 10 years; Male: 1; Female: 1\r\n* Age: 10 to < 13 years; Male: 1.2; Female: 1.2\r\n* Age: 13 to < 16 years; Male:1.5; Female: 1.4\r\n* Age >= 16 years; Male: 1.7; Female: 1.4Xx_NEWLINE_xXMale or female at least 18 years of age.Xx_NEWLINE_xXMale or female patients, ? 18 years of age at the time of obtaining informed consent.Xx_NEWLINE_xXMale or female, age 18 years or olderXx_NEWLINE_xXMale or female subjects age 18 or older.Xx_NEWLINE_xXSTRATUM A: Creatinine clearance >= 70 mL/min/1.73 m^2 or serum creatinine =< the maximum serum creatinine (mg/dL) based on age/gender as listed below:\r\n* 3 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male), 1.4 (female)\r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXSTRATUM B: Creatinine clearance >= 70 mL/min/1.73 m^2 or serum creatinine =< the maximum serum creatinine (mg/dL) based on age/gender as listed below:\r\n* 3 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male), 1.4 (female)\r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXSTRATUM C: Creatinine clearance >= 70 mL/min/1.73 m^2 or serum creatinine =< the maximum serum creatinine (mg/dL) based on age/gender as listed below:\r\n* 3 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male), 1.4 (female)\r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXMale or female, ? 18 years of ageXx_NEWLINE_xXSubject is male or female and at least 18 years of age.Xx_NEWLINE_xXFemale or male, age ? 18 years.Xx_NEWLINE_xXMale or female patients, ? 18 years of age at the time of obtaining informed consent.Xx_NEWLINE_xXMale and non-pregnant female patients 16-70 years of age (inclusive)Xx_NEWLINE_xXAdult male or female participants aged >=20 years (Japan) or >=18 years (United States).Xx_NEWLINE_xXAge >18 year at the time of obtaining informed consent, male or female.Xx_NEWLINE_xXMale or female subjects must be at least 18 years of age.Xx_NEWLINE_xXA serum creatinine =< upper limit of normal (ULN) based on age/gender as listed below:\r\n* 1 to < 2 years: Male & Female: 0.6 mg/dL\r\n* 2 years < 6 years: Male & Female: 0.8 mg/dL\r\n* 6 years < 10 years: Male & Female: 1.0 mg/dL\r\n* 10 years < 13 years: Male & Female: 1.2 mg/dL\r\n* 13 years < 16 years: Male: 1.5 mg/dL; Female: 1.4 mg/dL\r\n* > 16 years: Male: 1.7 mg/dL; Female: 1.4 mg/dLXx_NEWLINE_xXMale and non-pregnant females who are aged 18 years or older at the time of provision of informed consent.Xx_NEWLINE_xXMale or female patients aged ? 18 years at time of informed consent;Xx_NEWLINE_xXMale or female patients ?18 years of age.Xx_NEWLINE_xXMale and female patients ? 18 years of age;Xx_NEWLINE_xXMale; 18 years of age and olderXx_NEWLINE_xXFemale or male patients, >18 years of age, able to understand and give written informed consent.Xx_NEWLINE_xXFemale participants 18 years or older.Xx_NEWLINE_xXAge: Male or female age ? 2 years and < 22 years unless enrolled in Part EXx_NEWLINE_xXCELL PROCUREMENT: Serum creatinine =< 1.5 x upper limit of normal (ULN), obtained within 72 hrs prior to procurement\r\n* For pediatric patients, adequate renal function is defined as below:\r\n** Age: Maximum Serum Creatinine (mg/dL)\r\n** 3 to < 6 years: =< 0.8 (male and female)\r\n** 6 to < 10 years: =< 1 (male and female)\r\n** 10 to < 13 years: =< 1.2 (male and female)\r\n** 13 to < 16 years: =< 1.5 (male), =< 1.4 (female)\r\n** 16 to < 18 years: =< 1.7 (male), =< 1.4 (female)Xx_NEWLINE_xXLYMPHODEPLETION: Serum creatinine =< 1.5 x ULN, obtained within 72 hrs prior to lymphodepletion\r\n* For pediatric patients, adequate renal function is defined as below:\r\n** Age: Maximum Serum Creatinine (mg/dL)\r\n** 3 to < 6 years: =< 0.8 (male and female)\r\n** 6 to < 10 years: =< 1 (male and female)\r\n** 10 to < 13 years: =< 1.2 (male and female)\r\n** 13 to < 16 years: =< 1.5 (male), =< 1.4 (female)\r\n** 16 to < 18 years: =< 1.7 (male), =< 1.4 (female)Xx_NEWLINE_xXFemale ? 18 years old.Xx_NEWLINE_xXMale or female aged ? 18 years;Xx_NEWLINE_xXPART 2 GROUP 1 INCLUSION CRITERIA: Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 OR a serum creatinine based on age/gender normal as follows:\r\n* 1 to < 2 years: Male and female: 0.6\r\n* 2 to < 6 years: Male and female: 0.8\r\n* 6 to < 10 years: Male and female: 1\r\n* 10 to < 13 years: Male and female: 1.2\r\n* 13 to < 16 years: Male: 1.5; Female: 1.4\r\n* 16 years and above: Male: 1.7; Female: 1.4Xx_NEWLINE_xXPART 2 GROUP 2A INCLUSION CRITERIA: Creatinine clearance or radioisotope GFR >= 70 mL/min/1.73 m^2 OR a serum creatinine based on age/gender normal as follows:\r\n* 1 to < 2 years: Male and female: 0.6\r\n* 2 to < 6 years: Male and female: 0.8\r\n* 6 to < 10 years: Male and female: 1\r\n* 10 to < 13 years: Male and female: 1.2\r\n* 13 to < 16 years: Male: 1.5; Female: 1.4\r\n* 16 years and above: Male: 1.7; Female: 1.4Xx_NEWLINE_xXPART 2 GROUP 3 INCLUSION CRITERIA: Creatinine clearance or radioisotope GFR >= 70 mL/min/1.73 m^2 OR a serum creatinine based on age/gender normal as follows:\r\n* 1 to < 2 years: Male and female: 0.6\r\n* 2 to < 6 years: Male and female: 0.8\r\n* 6 to < 10 years: Male and female: 1\r\n* 10 to < 13 years: Male and female: 1.2\r\n* 13 to < 16 years: Male: 1.5; Female: 1.4\r\n* 16 years and above: Male: 1.7; Female: 1.4Xx_NEWLINE_xXMale or female patients, age ?18 years (?19 years for South Korea)Xx_NEWLINE_xXPRIOR TO CELL PROCUREMENT: For patients < 18 years old use the following table for serum creatinine requirements:\r\n* Age (years): Maximum serum creatinine (mg/dL)\r\n* 3 to < 6: ? 0.8 (male and female)\r\n* 6 to < 10: ? 1.0 (male and female)\r\n* 10 to < 13: ? 1.2 (male and female)\r\n* 13 to < 16: ? 1.5 (male), ? 1.4 (female)\r\n* ? 16 and < 18: ? 1.7 (male), ? 1.4 (female)Xx_NEWLINE_xXPRIOR TO INFUSION OF ATLCAR.CD30 CELLS: For patients < 18 years old use the following table for serum creatinine requirements:\r\n* Age (years): Maximum serum creatinine (mg/dL)\r\n* 3 to < 6: ? 0.8 (male and female)\r\n* 6 to < 10: ? 1.0 (male and female)\r\n* 10 to < 13: ? 1.2 (male and female)\r\n* 13 to < 16: ? 1.5 (male), ? 1.4 (female)\r\n* ? 16 and < 18: ? 1.7 (male), ? 1.4 (female)Xx_NEWLINE_xXMale or female at least 22 years of age or older.Xx_NEWLINE_xXMale or female aged ?18 years.Xx_NEWLINE_xXFemale or male, 18 years of age or older.Xx_NEWLINE_xXMale or female patients ? 18 years of ageXx_NEWLINE_xXPatients (male or female) ? 18 years of age.Xx_NEWLINE_xXMale or female patients ?18 years of ageXx_NEWLINE_xXMale > 18 years of ageXx_NEWLINE_xXMale or female, aged at least 18 years.Xx_NEWLINE_xXFemale or male patients 18 years of age or olderXx_NEWLINE_xXMale or Female ? 18 years of ageXx_NEWLINE_xXMale patientsXx_NEWLINE_xXMale or female participants age 2 years to less than18 years and less than or equal to 25 years for osteosarcoma subjects at the time of informed consent.Xx_NEWLINE_xXMale or female ? 18 years of ageXx_NEWLINE_xXMale or female patients ? 18 years of ageXx_NEWLINE_xXMale or female ? 18 years of ageXx_NEWLINE_xXMale or female participants 18 years or older.Xx_NEWLINE_xXAge ?18 years male or female.Xx_NEWLINE_xXMale or female ? 18 years of age.Xx_NEWLINE_xXSerum creatinine based on age or creatinine clearance or radioisotope glomerular filtration rate (GFR) > 70 ml/min/ml/min/1.73 m^2\r\n* Age 1 to < 2 male 0.6 female 0.6\r\n* Age 2 to < 6 male 0.8 female 0.8\r\n* Age 6 to < 10 male 1 female 1\r\n* Age 10 to < 13 male 1.2 female 1.2\r\n* Age 13 to < 16 male 1.5 female 1.4\r\n* Age > 16 male 1.7 female 1.4Xx_NEWLINE_xXMale or female children, <13 years of ageXx_NEWLINE_xXMale or female subjects, age 18 years or older.Xx_NEWLINE_xXMale or female patients ? 18 years of age.Xx_NEWLINE_xXMale or female, age 18 years or older.Xx_NEWLINE_xXMale and female patients must be at least 18 years of age.Xx_NEWLINE_xXSerum creatinine based on age or creatinine clearance or radioisotope GFR > 70 ml/min/ml/min/1.73 m^2\r\n* Age 1 to < 2 maximum serum creatinine for male is 0.6; female is 0.6\r\n* Age 2 to < 6 maximum serum creatinine for male is 0.8; female is 0.8\r\n* Age 6 to < 10 maximum serum creatinine for male is 1; female is 1\r\n* Age 10 to < 13 maximum serum creatinine for male is 1.2; female is 1.2\r\n* Age 13 to < 16 maximum serum creatinine for male is 1.5; female is 1.4\r\n* Age >= 16 maximum serum creatinine for male is 1.7; female is 1.4Xx_NEWLINE_xXMale patients, 18 years of age or olderXx_NEWLINE_xXMale or female patients, ? 18 years of age at the time of obtaining informed consent.Xx_NEWLINE_xXMale or female patients from 6 months to ? 21 years old at the time of study enrollmentXx_NEWLINE_xXBe male or female at least 18 years of age (at the time consent is obtained);Xx_NEWLINE_xXMale or non-pregnant, non-lactating female patient at least 18 years of age at the time of consent;Xx_NEWLINE_xXMale or female ?18 years of ageXx_NEWLINE_xXParticipant must be male or female at least 18 years of age at time of screeningXx_NEWLINE_xXMale or female age 21 years or olderXx_NEWLINE_xXMale or female age ?18 years old;Xx_NEWLINE_xXMale or female, Age ? 18 years.Xx_NEWLINE_xXFemale, aged ?18 yearsXx_NEWLINE_xXMale or female patients ? 18 years of age.Xx_NEWLINE_xXIs a male or female ? 18 years of age, that has provided written informed consent.Xx_NEWLINE_xXMale or female ? 2 years of age;Xx_NEWLINE_xXAge >18 years of age; male or female.Xx_NEWLINE_xXMale or female patients, ? 18 years of age, able to understand and give written informed consent.Xx_NEWLINE_xXMale or female patient with age ? 18 yearsXx_NEWLINE_xXMale or female outpatient of ? 18 years of age or ? country's legal age for adult consentXx_NEWLINE_xXMale or female, 18 years or older.Xx_NEWLINE_xXMale or female patients ? 18 years of age on day of signing informed consent.Xx_NEWLINE_xXMale or female at least 12 years of age;Xx_NEWLINE_xXMale or female patients, ? 18 years of age at the time of obtaining informed consent.Xx_NEWLINE_xXMale or female, 18 years or older (at the time consent is obtained).Xx_NEWLINE_xXMale or female patients, ? 18 years of age, able to understand and give written informed consentXx_NEWLINE_xXSerum creatinine based on age/gender; patients that do not meet the criteria but have a 24 hour creatinine clearance or glomerular filtration rate (GFR) (radioisotope or iothalamate) >= 70 mL/min/1.73 m^2 are eligible\r\n* Age: maximum serum creatinine (mg/dL)\r\n** 1 to < 2 years: 0.6 (male and female)\r\n** 2 to < 6 years: 0.8 (male and female)\r\n** 6 to < 10 years: 1 (male and female)\r\n** 10 to < 13 years: 1.2 (male and female)\r\n** 13 to < 16 years: 1.5 (male) 1.4 (female)\r\n** >= 16 years: 1.7 (male) 1.4 (female)Xx_NEWLINE_xXFemale or male subjects ?18 years-of-age.Xx_NEWLINE_xXPatient is male or female 18 years or olderXx_NEWLINE_xXA serum creatinine based on age/gender as follows:\r\n* 1 month to < 6 months: 0.4 (male) 0.4 (female)\r\n* 6 months to < 1 year: 0.5 (male), 0.5 (female)\r\n* 1 to < 2 years: 0.6 (male), 0.6 (female)\r\n* 2 to < 6 years: 0.8 (male), 0.8 (female)\r\n* 6 to < 10 years: 1 (male), 1 (female)\r\n* 10 to < 13 years: 1.2 (male), 1.2 (female)\r\n* 13 to < 16 years: 1.5 (male), 1.4 (female)\r\n* >= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXA serum creatinine based on age/gender as follows: maximum serum creatinine (mg/dL)\r\n* 3 to < 6 years: 0.8 (male and female)\r\n* 6 to < 10 years: 1 (male and female)\r\n* 10 to < 13 years: 1.2 (male and female)\r\n* 13 to < 16 years: 1.5 (male)\t1.4 (female)\r\n* 16 to < 18 years: 1.7 (male)\t1.4 (female)Xx_NEWLINE_xXMale or female 18 years of age or olderXx_NEWLINE_xXMale or female, age ? 18 yearsXx_NEWLINE_xXMale or female is 1 to ? 18 years of age at the time of signing the Informed Consent Form / Informed Assent Form (ICF/IAF).Xx_NEWLINE_xXMale or non-pregnant, non-breastfeeding female, age 18 years or older at date of consent.Xx_NEWLINE_xXMale 18 years and olderXx_NEWLINE_xXMale or female subjects, age 18 years or olderXx_NEWLINE_xXMale or female subjects aged greater than or equal to (>=) 18 yearsXx_NEWLINE_xXMale or female ? 21 years of age at Screening Visit.Xx_NEWLINE_xXSubject is male or female, ? 18 years old at the time of signing the informed consent form (ICF).Xx_NEWLINE_xXMale or female patients age 18 years and older, inclusive, at the time of informed consentXx_NEWLINE_xXMale or female participants 18 years or older.Xx_NEWLINE_xXMust be male or female, 18 years of age or older, and of any ethnic or racial groupXx_NEWLINE_xXMale patients.Xx_NEWLINE_xXMale, age 45 to 80 yearsXx_NEWLINE_xXMale subjects must :Xx_NEWLINE_xXMale or female ?18 years of ageXx_NEWLINE_xXMale or female subjects ? 55 years of ageXx_NEWLINE_xXMale or female ? 18 years of age at time of consentXx_NEWLINE_xXMale subject must:Xx_NEWLINE_xXMale or female 16 years or older, at the time of signing the informed consent.Xx_NEWLINE_xXMale or female ?18 years of ageXx_NEWLINE_xXAre a male or female patient ?18 years old.Xx_NEWLINE_xXMale or female subjects aged ?18 yearsXx_NEWLINE_xXMale or non-pregnant, non-breastfeeding female at least 18 years of age. Patients aged at 12~18 years may be recruited but only at the site principle investigator's request and subject to IRB approval.Xx_NEWLINE_xXMale or female, age 18 years or olderXx_NEWLINE_xXMale or female patients over 18 years of ageXx_NEWLINE_xXMale or female ? 18 years of age.Xx_NEWLINE_xXMale or female participants aged 18 years or older.Xx_NEWLINE_xXMale or female participants 18 years or older.Xx_NEWLINE_xXFemale or male ?18 years of ageXx_NEWLINE_xXMale or female and ?18 years of age on day of signing informed consent.Xx_NEWLINE_xXMale or female ?18 years of ageXx_NEWLINE_xXMale or female aged at least 18 years. Aged at least 20 if Japanese.Xx_NEWLINE_xXMale patient aged, equal to, or more than,18 years old.Xx_NEWLINE_xXMale or female patients aged 18 - 75 years.Xx_NEWLINE_xXSubject is male or female and at least 18 years of age.Xx_NEWLINE_xXMale or Female at least 18 years of ageXx_NEWLINE_xXMale or female patients age ? 18 years of age at the time of informed consentXx_NEWLINE_xXMale or female subjects aged greater than or equal to (>=) 18 yearsXx_NEWLINE_xXMale or female subjects, age 18 years or older on day of signing consentXx_NEWLINE_xXMale or female subjects aged ?18 yearsXx_NEWLINE_xXAdult, at least 18 years of age, male or femaleXx_NEWLINE_xXSubjects may be male or female, and must be aged =/>18 years on the date of signing the informed consent form.Xx_NEWLINE_xXMale or female subjects aged ?18 yearsXx_NEWLINE_xXMale or female patients 18 years of age or older.Xx_NEWLINE_xXMale or female ? 18 years of ageXx_NEWLINE_xXMale or female subjects aged >/= 18 years.Xx_NEWLINE_xXMale or female ? 18 years of age at time of consent.Xx_NEWLINE_xXPatient is male or female aged ?18 years.Xx_NEWLINE_xXMale or female, aged at least 18 years.Xx_NEWLINE_xXMale and female subjects; age ? 18Xx_NEWLINE_xXFemale >=18 yearsXx_NEWLINE_xXAre a male or female participants ?18 years old.Xx_NEWLINE_xXMale or female aged 18 years and older.Xx_NEWLINE_xXFemale patients age 18 and older;Xx_NEWLINE_xXMale subjects of age ? 18 yearsXx_NEWLINE_xXMale or Female patients at least 18 years of ageXx_NEWLINE_xXMale aged 18 years and older.Xx_NEWLINE_xXMale or Female ? 18 years old at the time of signing the informed consent.Xx_NEWLINE_xXMale or female, aged 18 years or olderXx_NEWLINE_xXMale or female patients 18 years or olderXx_NEWLINE_xXMale or female patients 18 years or older diagnosed with Multiple Myeloma according to standard criteria who have not received prior treatmentXx_NEWLINE_xXMale or female patients ?18 years old.Xx_NEWLINE_xXMale patients >/= 18 years of ageXx_NEWLINE_xXMale or female, aged 18 years or olderXx_NEWLINE_xXMale or female patients >= 18 years of ageXx_NEWLINE_xXmale or female patients ? 18 years of age.Xx_NEWLINE_xXMale or female patients > 18 years of ageXx_NEWLINE_xXMale or female participants 18 years of age or older.Xx_NEWLINE_xXThe patient is male or female, age 18 years or olderXx_NEWLINE_xXMale or female patients 18 years or olderXx_NEWLINE_xXMale and female subjects aged greater than 18 yearsXx_NEWLINE_xXMale or female patients aged >/= 18 years oldXx_NEWLINE_xXMale or female patients 18 years of age or olderXx_NEWLINE_xXMale or female at least 18 years of age.Xx_NEWLINE_xXMale ?18 years of age.Xx_NEWLINE_xXMale subjects must:Xx_NEWLINE_xXMale or female subjects, age 18 years or olderXx_NEWLINE_xXMale or female ?18 years oldXx_NEWLINE_xXMale or female age 18 years or olderXx_NEWLINE_xXMale or female patient is ? 18 years old,Xx_NEWLINE_xXMale or female participants aged ?18 years at the time of screeningXx_NEWLINE_xXMale or female, at least 18 years of age at time of screeningXx_NEWLINE_xXFemale or male, 18 years of age or olderXx_NEWLINE_xXMale or female patients ? 18 years oldXx_NEWLINE_xXMale and female subjects 18 years of age and older at the time of screeningXx_NEWLINE_xXMale or female subjects aged > 18 yearsXx_NEWLINE_xXMale and female subjects aged 1 to 18 years, inclusive.Xx_NEWLINE_xXMale and female ? 18 years of age.Xx_NEWLINE_xXMale or female patients of at least 18 years of ageXx_NEWLINE_xXMale or female aged ? 18 yearsXx_NEWLINE_xXMale or female participants 18 years of age or older when written informed consent is obtained.Xx_NEWLINE_xXMale or female participants 18 years of age or older when written informed consent is obtained.Xx_NEWLINE_xXMale or female patients ? 18 years of age (only female patients in breast cancer cohort of Phase 2).Xx_NEWLINE_xXMale or female subjects aged ?18 years (or country-specific legal age of maturity, if >18 years)Xx_NEWLINE_xXMale or female outpatients (except where inpatient stay is required for medical need at the Investigator's discretion) at least 18 years of age at the time of informed consentXx_NEWLINE_xXmale or female greater than or equal to 18 years of ageXx_NEWLINE_xXMale or female 18 years of age or over.Xx_NEWLINE_xXMale participants who are ?18 years of ageXx_NEWLINE_xXMale or female patients 18 years or olderXx_NEWLINE_xXAge ? 18 years, male or female subjects.Xx_NEWLINE_xXMale or female, age 18 years or older.Xx_NEWLINE_xXMale or female ?18 years old.Xx_NEWLINE_xXMale or female subjects aged =/> 18 yearsXx_NEWLINE_xXPatient is an adult, female ? 18 years old at the time of informed consentXx_NEWLINE_xXAdult male or female ? 18 years of age at the time of signing the informed consent form (ICF).Xx_NEWLINE_xXMale or female subjects with age ? 18 years or the otherwise legal lower age according to the country of residence;Xx_NEWLINE_xXSubjects (male and female for Part A and female for Part B) will be at least 18 year of age.Xx_NEWLINE_xXMale or female subjects aged >/=18 yearsXx_NEWLINE_xXMale or female aged ? 18 yearsXx_NEWLINE_xXMale or female participants 18 years of age or older.Xx_NEWLINE_xXMale or female ?18 years of ageXx_NEWLINE_xXMale or female participants 18 years of age or older.Xx_NEWLINE_xXMale or female, 18 years of age or olderXx_NEWLINE_xXMale or female, at least 18 years of ageXx_NEWLINE_xXMale or female between 18 to 65 years of age, inclusive, at the time of signing the informed consent form;Xx_NEWLINE_xXAge ?15 years (US only), and 18-80 (rest of world (ROW)), male or female.Xx_NEWLINE_xXAdult male and female patients (18 to 75 years of age, inclusive);Xx_NEWLINE_xXAge 18 years or older; male or femaleXx_NEWLINE_xXMale or female at least 18 years of ageXx_NEWLINE_xXMale or female patients ? 18 years of ageXx_NEWLINE_xXMale or female of 18 to 85 years of age (inclusive);Xx_NEWLINE_xXMale or female subjects aged >/=21 yearsXx_NEWLINE_xXMale and female patients at least 18 years of ageXx_NEWLINE_xXMale or female patients, >= 18 years of age at the time of obtaining informed consent.Xx_NEWLINE_xXMale or female ?18 years of ageXx_NEWLINE_xXMale or female >=18 years of age.Xx_NEWLINE_xXMale or female patients 18 years of age or olderXx_NEWLINE_xXMale or female ?18 years of age.Xx_NEWLINE_xXMale or female subject ? 18 years of ageXx_NEWLINE_xXMale or female patients 18 years or olderXx_NEWLINE_xXMale or female patients, > 18 years of age.Xx_NEWLINE_xXMale and female patients aged ? 18 years.Xx_NEWLINE_xXAge 18 years or older, male or femaleXx_NEWLINE_xXMale or female >=12 months and <18 years of age at the time of signing the informed consent form.Xx_NEWLINE_xXMale or female at least 18 years of ageXx_NEWLINE_xXMale or female aged 18 years or older.Xx_NEWLINE_xXMale or female participants aged 2 to <18 years (5 to <18 years for Hodgkin lymphoma [HL])Xx_NEWLINE_xXMale or female patients 18 years or olderXx_NEWLINE_xXMale or female patients ?18 years old.Xx_NEWLINE_xXMale or female patient aged 18 years or older.Xx_NEWLINE_xXMale or female greater than or equal to 18 years of age.Xx_NEWLINE_xXMale and female patients from 1 month to less than 18 years of age.Xx_NEWLINE_xXMale Patients:Xx_NEWLINE_xXCreatinine clearance OR radioisotope glomerular filtration rate >= 70 mL/min/1.73m^2 or a serum creatinine based on age/gender as follows:\r\n                 Age                     Maximum Serum Creatine (mg/dL)\r\n* 1month to < 6 months          male: 0.4  female: 0.4\r\n* 6 months to <1 year             male: 0.5  female: 0.5\r\n* 1 year to < 2 years               male: 0.6  female: 0.6     \r\n* 2 to < 6 years                       male: 0.8  female: 0.8\r\n* 6 to < 10 years                     male: 1     female: 1\r\n* 10 to < 13 years                   male: 1.2  female: 1.2\r\n* 13 to < 16 years                   male: 1.5  female: 1.4\r\n* >= 16 years                          male: 1.7  female: 1.4Xx_NEWLINE_xXMale or female ?18 years of age at the time of informed consentXx_NEWLINE_xXCreatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows:\r\n* Age: maximum serum creatinine (mg/dL)\r\n1 to < 2 years: 0.6 (male), 0.6 (female)\r\n2 to < 6 years: 0.8 (male), 0.8 (female)\r\n6 to < 10 years: 1 (male), 1 (female)\r\n10 to < 13 years: 1.2 (male), 1.2 (female)\r\n13 to < 16 years: 1.5 (male), 1.4 (female)\r\n>= 16 years: 1.7 (male), 1.4 (female)Xx_NEWLINE_xXMale or female cigarette smokers, 18-75 yearsXx_NEWLINE_xXMale or female patients >= 18 years oldXx_NEWLINE_xXMale or female age ?18 yearsXx_NEWLINE_xXMale and female subjects 18 years and olderXx_NEWLINE_xXFemale or male at least 18 years of age.Xx_NEWLINE_xXFemale or male of at least 18 years of age.Xx_NEWLINE_xXMale or female participants aged 18 years or older.Xx_NEWLINE_xXSubject is female and is at least 18 years oldXx_NEWLINE_xXMale or female, age >=18 years (at the time consent is obtained).Xx_NEWLINE_xXSerum creatinine at or below the upper limit of normal (ULN) for age and gender (mg/dL): \r\n* 1 month (mo) to < 6 months: male: 0.4; female: 0.4\r\n* 6 mo to < 1 year: male: 0.5; female: 0.5\r\n* 1 year to < 2 years: male: 0.6; female: 0.6\r\n* 2 to < 6 years: male: 0.8; female: 0.8\r\n* 6 to < 10 years: male: 1; female: 1\r\n* 10 to < 13 years: male: 1.2; female: 1.2\r\n* 13 to < 16 years: male:1.5; female: 1.4\r\n* >= 16 years: male: 1.7; female: 1.4Xx_NEWLINE_xXMale or female, at least 18 years of age, inclusive. 2. Subject has a symptomatic MPE requiring intervention. For an effusion to be defined as malignant, at least one of the following must be true:Xx_NEWLINE_xXMale or female patients aged >18 yearsXx_NEWLINE_xXMale or female subjects at least 18 years of age at the time of consent;Xx_NEWLINE_xXMale patientsXx_NEWLINE_xXMale and female patients aged 18 to 70 years, inclusive;Xx_NEWLINE_xXMale or female in- or out-patient from birth to < 18 years at the time of randomization.Xx_NEWLINE_xXFemale aged ?18 years of age.Xx_NEWLINE_xXMale or female, age ? 18 years and ? 70 years. Patients aged ? 65 years must have a Sorror score ? 3Xx_NEWLINE_xXMale or female, age ? 18 years and ? 65 yearsXx_NEWLINE_xXMale or female, age ? 16 and ? 75 years (If applicable, local legal requirements for donors under the age of 18 will be followed)Xx_NEWLINE_xXMale or female, ? 18 years of age at the time of signing the informed consent documentXx_NEWLINE_xXMale subjects must:Xx_NEWLINE_xXMale subjects must:Xx_NEWLINE_xXMale or female, 18 years or older (at the time consent is obtained)Xx_NEWLINE_xXMale or female subjects ? 18 and ? 75 years of ageXx_NEWLINE_xXMale subjects age 50 and older.Xx_NEWLINE_xXSubject must be female ? 40 years of ageXx_NEWLINE_xXFemale or male patients at least 18 years of ageXx_NEWLINE_xXMale 18 to 60 years oldXx_NEWLINE_xXFemale 18 to 50 years oldXx_NEWLINE_xXA male or female, aged 18 years or older at the time of study entry.Xx_NEWLINE_xXMale and Female patients 18 years of age and olderXx_NEWLINE_xXPatient is ? 18 years old at the time of the drug administration (Patient may be male or female of any race / ethnicity.)Xx_NEWLINE_xXFemale over 21 years of age;Xx_NEWLINE_xXMale patientsXx_NEWLINE_xXMale or female subjects age 18 or olderXx_NEWLINE_xXMale or female, age 18 years or olderXx_NEWLINE_xXMale patients age ?18 years oldXx_NEWLINE_xXMale, age between 50-70 years oldXx_NEWLINE_xXAdult male >/= 18 years of ageXx_NEWLINE_xXThe patient is maleXx_NEWLINE_xXMale or female, age ? 18 years old at the time of consent.Xx_NEWLINE_xXMale and female patients 18 years of age or older.Xx_NEWLINE_xXMale or female aged 18-79Xx_NEWLINE_xXMale or female participants 18 years or older.Xx_NEWLINE_xXMale or female subjects who are at least 18 years of age;Xx_NEWLINE_xXMale or female age ? 18 years at the time of informed consentXx_NEWLINE_xXIs a male or female participant of 18 years or older.Xx_NEWLINE_xXMale or female, ? 18 years of age.Xx_NEWLINE_xXMale or female subject aged 18 years or older.Xx_NEWLINE_xXSubjects (male or female) ? 18 years of ageXx_NEWLINE_xXIs a male or female participant aged 18 years or older.Xx_NEWLINE_xXMale or female subjects 2 to ? 21 years of age at the time of informed consent/assent.Xx_NEWLINE_xXFemale participants aged 18 years or older who are postmenopausal.Xx_NEWLINE_xXMale or female patients ? 18 years of ageXx_NEWLINE_xX